[1] Koukourakis MI, Giatromanolaki A, Sivridis E,et al.Squamous cell head and neck cancer, evidence of angio genic regeneration during radiotherapy[J]. Anticancer Res,2001, 21(6B): 4301-4309.
[2] GuptaVK, Jaskowiak NT, Beckett MA, et al. Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance[J]. Cancer J, 2002, 8(1): 47-54.
[3] Shimada H, Hoshino T, Okazumi S, et al. Expression of angiogenic factors predicts response to chemoradioth erapy and prognosis of oesophageal squamous cell carcinoma[J].Br J Cancer, 2002, 86(4): 552-557.
[4] Hui EP, Chan AT, Pezzella F, et al. Coexpression of hypoxia-inducible factors 1 alpha and 2 alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival[J].Clin Cancer Res, 2002, 8(8): 2595-2604.
[5] Homer JJ, Greenman J, Stafford ND. The expression of vascular endothelial growth factor (VEGF) and VEGF-C in early laryngeal cancer, relationship with radioresistance[J].Clin Otolaryngol, 2001, 26(6): 498-504.
[6] Schmitt O, Schubert C, Feyerabend T, et al. Preferential topography of proteins regulating vascularization and apoptosis in a MX1 xenotransplant after treatment with hypoxia, hyperthermia, ifosfamide, and irradiation[J]. Am J Clin Oncol, 2002, 25(4): 325-336.
[7] Linderholm BK, Lindahl T, Holmberg L,et al. The expression of vascular endothelial growth factor corre lates with mutant p53 and poor prognosis in human breast cancer[J]. Cancer Res, 2001, 61(5): 2256-2260.
[8] Johansson M, Brannstrom T, Bergenheim AT, et al. Spatial expression of VEGF-A in human glioma[J]. J Neurooncol,2002, 59(1): 1-6.
[9] Arinaga M, Noguchi T, Takeno S, et al. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma[J]. Cancer, 2003, 97(2): 457-464.
[10] Ando S, Nojima K, Ishihara H, et al. Induction by carbonion irradiation of the expression of vascular endothelial growth factor in lung carcinoma cells[J]. Int J Radiat Bid,2000, 76(8): 1121-1127.
[11] Katoh O, Takahashi T, Oguri T, et al. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor[J]. Cancer Res,1998, (23): 5565-5569.
[12] Bachtiary B, Selzer E, Knocke TH, et al. Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival[J].Cancer Lett, 2002, 179(2): 197-203.
[13] Griffin R J, Williams BW, Wild R, et al. Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response.[J]. Cancer Res, 2002, 62(6): 1702-1706.
[14] Gorski DH, Beckett MA, Jaskowiak NT, et al. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation[J]. Cancer Res, 1999, 59(14): 3374-3378.
[15] Ning S, Laird D, Cherrington JM, et al. The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation[J]. Radiat Res, 2002, 157(1): 45-51.
[16] Solomon B, Hagekyriakou J, Trivett MK, et al. EGFR blockade with ZD1839("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. Epidermal growth factor receptor[J]. Int J Radiat Oncol Bid Phys,2003, 55(3): 713-723.
[17] Greco O, Marples B, Dachs GU, et al. Novel chimeric gene promoters responsive to hypoxia and ionizing radiation[J].Gene Ther, 2002, 9(20): 1403-1411.